Dallas, TX - October 26, 2016
In October 2016, Behavioral Health Group (“BHG”), a leading provider of outpatient substance abuse treatment services, acquired Affinity Health Group's two clinics in Virginia, bringing the company’s total clinic count to 37 locations across ten states. Located in Chesapeake and Virginia Beach, VA, the clinics newly establish a BHG presence in the state, while simultaneously strengthening the company’s established footprint across the mid-Atlantic and southeast regions and further diversifying BHG’s suite of treatment services.
“We are pleased to welcome our new colleagues to BHG,” said Dwight Mussleman, Chief Development Officer of BHG. “A fundamental component of BHG’s strategy is to develop a regional platform whereby BHG can leverage resources to better serve communities and patients. The addition of these two treatment centers is the next step in our national expansion plans.”
The previous owners of the treatment centers are happy that BHG will continue a patient-centric philosophy by offering individuals personalized treatment in accordance with best practices. “It was important to us to transfer our treatment centers to a company that is focused on quality care and that has a passion and genuine concern for our patients,” stated Judd Mendelson, Chief Executive Offer and partner in Affinity Health Group. “In addition, BHG made the sales process very easy and we would recommend them to any treatment center owner looking to sell.”
About Behavioral Health Group
Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. BHG utilizes pharmacotherapy (maintenance and detoxification) and behavioral therapy (counseling) to treat both the bio-chemical and psychosocial aspects of addiction. In doing so, BHG offers patients their best opportunity for a successful recovery. With 37 outpatient treatment centers across the Midwest/South/Southeast/Mid-Atlantic, BHG provides a critical service to thousands of individuals and their communities across the country. BHG treatment centers are accredited by The Joint Commission.
Frontenac is a leading private equity firm, based in Chicago. The firm focuses on investing in lower middle market buyout transactions in the food, industrial, and services industries. Frontenac works in partnership with proven operating leaders, through our executive-centric approach called CEO1ST, to identify, acquire, and build market leading companies through transformational acquisitions and operational excellence. The firm has built a leading franchise working with over 225 owners of mid-sized businesses, almost always families or founders, as they address complex transition issues of liquidity, management enhancement, and growth planning. For more information, please visit www.frontenac.com.